1. Market Research
  2. > Pharmaceutical
  3. > Drug Discovery and Development Market Trends
  4. > Ureter Cancer Global Clinical Trials Review, H1, 2014

Ureter Cancer Global Clinical Trials Review, H1, 2014

  • April 2014
  • -
  • Global Data
  • -
  • 89 pages

Ureter Cancer Global Clinical Trials Review, H1, 2014

Summary

GlobalData's clinical trial report, “Ureter Cancer Global Clinical Trials Review, H1, 2014" provides data on the Ureter Cancer clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Ureter Cancer. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Ureter Cancer. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table Of Contents

Ureter Cancer Global Clinical Trials Review, H1, 2014
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Ureter Cancer 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Ureter Cancer to Oncology Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Ureter Cancer to Oncology Clinical Trials 18
Clinical Trials by Phase 19
In Progress Trials by Phase 20
Clinical Trials by Trial Status 21
Clinical Trials by End Point Status 22
Unaccomplished Trials of Ureter Cancer 23
Subjects Recruited Over a Period of Time 25
Clinical Trials by Sponsor Type 26
Prominent Sponsors 27
Top Companies Participating in Ureter Cancer Therapeutics Clinical Trials 28
Prominent Drugs 30
Clinical Trial Profiles 31
Clinical Trial Overview of Top Companies 31
Takeda Pharmaceutical Company Limited 31
Clinical Trial Overview of Takeda Pharmaceutical Company Limited 31
Oncogenex Pharmaceuticals, Inc. 32
Clinical Trial Overview of Oncogenex Pharmaceuticals, Inc. 32
Merck and Co., Inc. 33
Clinical Trial Overview of Merck and Co., Inc. 33
Eli Lilly and Company 34
Clinical Trial Overview of Eli Lilly and Company 34
Eisai Co., Ltd. 35
Clinical Trial Overview of Eisai Co., Ltd. 35
AstraZeneca PLC 36
Clinical Trial Overview of AstraZeneca PLC 36
Amgen Inc. 37
Clinical Trial Overview of Amgen Inc. 37
Altor BioScience Corporation 38
Clinical Trial Overview of Altor BioScience Corporation 38
Across Barriers GmbH 39
Clinical Trial Overview of Across Barriers GmbH 39
Clinical Trial Overview of Top Institutes / Government 40
National Cancer Institute 40
Clinical Trial Overview of National Cancer Institute 40
Memorial Sloan Kettering Cancer Center 41
Clinical Trial Overview of Memorial Sloan Kettering Cancer Center 41
Southwest Oncology Group 42
Clinical Trial Overview of Southwest Oncology Group 42
National Bladder Cancer Collaborative Group 43
Clinical Trial Overview of National Bladder Cancer Collaborative Group 43
European Organization for Research and Treatment of Cancer 44
Clinical Trial Overview of European Organization for Research and Treatment of Cancer 44
University of California, Davis 45
Clinical Trial Overview of University of California, Davis 45
The University of Texas M. D. Anderson Cancer Center 46
Clinical Trial Overview of The University of Texas M. D. Anderson Cancer Center 46
Mayo Clinic 47
Clinical Trial Overview of Mayo Clinic 47
Medical Research Council 48
Clinical Trial Overview of Medical Research Council 48
Princess Margaret Hospital 49
Clinical Trial Overview of Princess Margaret Hospital 49
Five Key Clinical Profiles 50
Appendix 86
Abbreviations 86
Definitions 86
Research Methodology 87
Secondary Research 87
About GlobalData 88
Contact Us 88
Disclaimer 88
Source 89

List of Tables
Ureter Cancer Therapeutics, Global, Clinical Trials by Region, 2014* 7
Ureter Cancer Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Ureter Cancer Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Ureter Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2014* 10
Ureter Cancer Therapeutics Clinical Trials, Europe, Top Five Countries, 2014* 11
Ureter Cancer Therapeutics Clinical Trials, North America, Top Countries, 2014* 12
Ureter Cancer Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014* 13
Ureter Cancer Therapeutics Clinical Trials, Central and South America, Top Countries, 2014* 14
Proportion of Ureter Cancer to Oncology Clinical Trials, G7 Countries (%), 2014* 15
Ureter Cancer Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Ureter Cancer Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Ureter Cancer to Oncology Clinical Trials, E7 Countries (%), 2014* 18
Ureter Cancer Therapeutics, Global, Clinical Trials by Phase, 2014* 19
Ureter Cancer Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 20
Ureter Cancer Therapeutics, Global, Clinical Trials by Trial Status, 2014* 21
Ureter Cancer Therapeutics Clinical Trials, Global, by End Point Status, 2014* 22
Ureter Cancer Therapeutics, Global, Suspended Clinical Trials, 2014* 23
Ureter Cancer Therapeutics, Global, Withdrawn Clinical Trials, 2014* 23
Ureter Cancer Therapeutics, Global, Terminated Clinical Trials, 2014* 24
Ureter Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 25
Ureter Cancer Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 26
Ureter Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 27
Ureter Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 29
Ureter Cancer Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 30
Ureter Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Takeda Pharmaceutical Company Limited, 2014* 31
Ureter Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Oncogenex Pharmaceuticals, Inc., 2014* 32
Ureter Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck and Co., Inc., 2014* 33
Ureter Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Eli Lilly and Company, 2014* 34
Ureter Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Eisai Co., Ltd., 2014* 35
Ureter Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2014* 36
Ureter Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Amgen Inc., 2014* 37
Ureter Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Altor BioScience Corporation, 2014* 38
Ureter Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Across Barriers GmbH, 2014* 39
Ureter Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by National Cancer Institute, 2014* 40
Ureter Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Memorial Sloan Kettering Cancer Center, 2014* 41
Ureter Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Southwest Oncology Group, 2014* 42
Ureter Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by National Bladder Cancer Collaborative Group, 2014* 43
Ureter Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by European Organization for Research and Treatment of Cancer, 2014* 44
Ureter Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by University of California, Davis, 2014* 45
Ureter Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Texas M. D. Anderson Cancer Center, 2014* 46
Ureter Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Mayo Clinic, 2014* 47
Ureter Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Medical Research Council, 2014* 48
Ureter Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Princess Margaret Hospital, 2014* 49

List of Figures
Ureter Cancer Therapeutics, Global, Clinical Trials by Region (%), 2014* 7
Ureter Cancer Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Ureter Cancer Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Ureter Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2014* 10
Ureter Cancer Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014* 11
Ureter Cancer Therapeutics Clinical Trials, North America, Top Countries (%), 2014* 12
Ureter Cancer Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2014* 13
Proportion of Ureter Cancer to Oncology Clinical Trials, G7 Countries (%), 2014* 15
Ureter Cancer Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Ureter Cancer Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Ureter Cancer to Oncology Clinical Trials, E7 Countries (%), 2014* 18
Ureter Cancer Therapeutics, Global, Clinical Trials by Phase (%), 2014* 19
Ureter Cancer Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 20
Ureter Cancer Therapeutics, Global, Clinical Trials by Trial Status, 2014* 21
Ureter Cancer Therapeutics Clinical Trials, Global, by End Point Status, 2014* 22
Ureter Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 25
Ureter Cancer Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 26
Ureter Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 27
Ureter Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 28
Ureter Cancer Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 30
GlobalData Methodology 87

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

  • $ 5650
  • Industry report
  • August 2016
  • by MarketsandMarkets

The global clinical trial management system (CTMS) market is estimated to grow at a CAGR of 11.5% from 2016 to 2021, to reach USD 920.0 billion by 2021. The adoption of CTMS software is on the rise across ...

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

  • $ 5650
  • Industry report
  • October 2016
  • by MarketsandMarkets

The global CRO services market is estimated to grow at a CAGR of 7.4% from 2016 to 2021, to reach USD 41.86 billion by 2021 from USD 29.29 billion in 2016. Growth in this market is primarily attributed ...

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

  • $ 4157
  • Industry report
  • November 2016
  • by Stratistics MRC

According to Stratistics MRC, the Global Clinical Trial Management System (CTMS) market is expected to grow from $493.58 million in 2015 to reach $1118.58 million by 2022 with a CAGR of 12.4%. Huge research ...


ref:plp2014

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.